JP2002526472A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526472A5
JP2002526472A5 JP2000574069A JP2000574069A JP2002526472A5 JP 2002526472 A5 JP2002526472 A5 JP 2002526472A5 JP 2000574069 A JP2000574069 A JP 2000574069A JP 2000574069 A JP2000574069 A JP 2000574069A JP 2002526472 A5 JP2002526472 A5 JP 2002526472A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574069A
Other languages
Japanese (ja)
Other versions
JP3926983B2 (ja
JP2002526472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/022013 external-priority patent/WO2000017159A1/en
Publication of JP2002526472A publication Critical patent/JP2002526472A/ja
Publication of JP2002526472A5 publication Critical patent/JP2002526472A5/ja
Application granted granted Critical
Publication of JP3926983B2 publication Critical patent/JP3926983B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000574069A 1998-09-23 1999-09-21 アリールスルホンアニリドウレア Expired - Fee Related JP3926983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10088898P 1998-09-23 1998-09-23
US60/100,888 1998-09-23
PCT/US1999/022013 WO2000017159A1 (en) 1998-09-23 1999-09-21 Arylsulfonanilide ureas

Publications (3)

Publication Number Publication Date
JP2002526472A JP2002526472A (ja) 2002-08-20
JP2002526472A5 true JP2002526472A5 (https=) 2005-12-22
JP3926983B2 JP3926983B2 (ja) 2007-06-06

Family

ID=22282047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574069A Expired - Fee Related JP3926983B2 (ja) 1998-09-23 1999-09-21 アリールスルホンアニリドウレア

Country Status (23)

Country Link
US (3) US6214880B1 (https=)
EP (1) EP1115701B1 (https=)
JP (1) JP3926983B2 (https=)
KR (1) KR100642184B1 (https=)
CN (1) CN100335461C (https=)
AT (1) ATE240940T1 (https=)
AU (1) AU747663B2 (https=)
BR (1) BR9913903A (https=)
CA (1) CA2343204C (https=)
CZ (1) CZ2001934A3 (https=)
DE (1) DE69908156T2 (https=)
DK (1) DK1115701T3 (https=)
EA (1) EA003924B1 (https=)
ES (1) ES2194547T3 (https=)
HU (1) HUP0103884A3 (https=)
IL (2) IL142066A0 (https=)
NO (1) NO20011453L (https=)
NZ (1) NZ510435A (https=)
PL (1) PL198394B1 (https=)
PT (1) PT1115701E (https=)
SK (1) SK284757B6 (https=)
WO (1) WO2000017159A1 (https=)
ZA (1) ZA200102033B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508644D0 (en) * 1995-04-28 1995-06-14 Exxon Chemical Patents Inc Fuel compositions
DE69908156T2 (de) * 1998-09-23 2003-12-24 Tularik, Inc. Arylsulfonanilid-harnstoffe
US6316503B1 (en) * 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
RU2268054C2 (ru) * 1999-07-29 2006-01-20 Амджен Инк. Сочетанная терапия с использованием пентафторбензолсульфонамидов
US6664259B2 (en) 2000-03-16 2003-12-16 Smithkline Beecham Corporation Il-8 receptor antagonists
CO5280089A1 (es) * 2000-03-16 2003-05-30 Smithkline Beecham Corp Antagonistas del receptor il-8
UY26627A1 (es) * 2000-03-24 2001-09-28 Smithkline Beecham Corp Antagonistas de receptores de il-8
WO2002020463A2 (en) * 2000-09-05 2002-03-14 Tularik Inc. Fxr modulators
WO2002039958A2 (en) 2000-11-03 2002-05-23 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US6646009B2 (en) 2001-02-28 2003-11-11 Temple University — Of Commonwealth System of Higher Education N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
AUPR738301A0 (en) * 2001-08-30 2001-09-20 Starpharma Limited Chemotherapeutic agents
CA2474702A1 (en) * 2002-01-30 2003-08-07 Tularik Inc Heterocyclic arylsulfonamidobenzylic compounds
JP4434744B2 (ja) * 2002-01-30 2010-03-17 アムジェン インコーポレイテッド アリールスルホンアミドベンジル化合物
EP1534284B1 (en) 2002-02-28 2011-07-27 Temple University - Of The Commonwealth System of Higher Education Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
TW200418812A (en) * 2002-10-29 2004-10-01 Smithkline Beecham Corp IL-8 receptor antagonists
MXPA06001566A (es) * 2003-08-12 2006-05-15 Amgen Inc Compuestos arilsulfonamidobencilicos.
US20050124664A1 (en) * 2003-10-30 2005-06-09 Eric Sartori Urea thiadiazole inhibitors of plasminogen activator inhibior-1
US20050154455A1 (en) * 2003-12-18 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050261762A1 (en) * 2004-05-21 2005-11-24 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
US20060062822A1 (en) * 2004-09-21 2006-03-23 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20070027530A1 (en) * 2005-07-26 2007-02-01 Medtronic Vascular, Inc. Intraluminal device, catheter assembly, and method of use thereof
FI20055498A0 (fi) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamidijohdannaisia
US20070067020A1 (en) * 2005-09-22 2007-03-22 Medtronic Vasular, Inc. Intraluminal stent, delivery system, and a method of treating a vascular condition
US8097626B2 (en) * 2006-04-21 2012-01-17 Glaxosmithkline Llc IL-8 receptor antagonists
PL2009992T3 (pl) * 2006-04-21 2012-11-30 Glaxosmithkline Llc Antagoniści receptora IL-8
EP2094268A2 (en) * 2006-05-26 2009-09-02 Bayer HealthCare, LLC Drug combinations with substituted diaryl ureas for the treatment of cancer
CL2007001829A1 (es) * 2006-06-23 2008-01-25 Smithkline Beecham Corp P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
AU2008347024A1 (en) * 2007-10-19 2009-07-16 Omm Scientific, Inc. Methods of inhibiting bacterial virulence and compounds relating thereto
WO2010123591A2 (en) * 2009-01-09 2010-10-28 The Uab Research Foundation Small molecule inhibitors of nads, namnat, and nmnat
US9444712B2 (en) 2012-11-21 2016-09-13 Cisco Technology, Inc. Bandwidth on-demand services in multiple layer networks
WO2014080615A1 (ja) * 2012-11-21 2014-05-30 日本曹達株式会社 非フェノール系化合物を用いた記録材料
EP3438091A4 (en) * 2016-03-30 2019-11-27 Ajinomoto Co., Inc. CONNECTION WITH INCREASING ACTIVITY FOR ACTION OF GLUCAGON LIKE PEPTIDE-1 RECEPTOR

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
DE622494C (de) 1932-01-03 1935-11-29 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Mono- bzw. Polynitropolysulfonen und deren Reduktionsprodukten
US2358365A (en) 1940-08-03 1944-09-19 Parke Davis & Co Sulphonamide derivatives and process for obtaining the same
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
CH362688A (de) 1957-09-10 1962-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
GB938890A (en) 1961-02-03 1963-10-09 Boots Pure Drug Co Ltd New fungicidal compositions and compounds
CH504416A (de) 1966-12-05 1971-03-15 Ciba Geigy Ag Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (nl) 1970-04-13 1984-07-16 Minnesota Mining & Mfg Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking.
FR2456731A1 (fr) * 1979-05-16 1980-12-12 Choay Sa Nouveaux derives substitues d'ary
DE3623184A1 (de) 1986-07-10 1988-01-14 Kali Chemie Ag Verfahren zur herstellung von n-fluorsulfonamiden
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
DE3905075A1 (de) 1989-02-18 1990-08-30 Hoechst Ag Benzolsulfonamide und verfahren zu ihrer herstellung
FR2645537B1 (fr) 1989-04-05 1994-03-04 Fabre Medicament Pierre Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique
FR2665440B1 (fr) 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
DE69129611T2 (de) 1990-08-20 1998-12-17 Eisai Co., Ltd., Tokio/Tokyo Sulfonamid-Derivate
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
PT896533E (pt) 1996-02-22 2004-02-27 Tularik Inc Pentafluorobenzenosulfonamidas e analogos
PT939627E (pt) * 1996-07-19 2004-02-27 Tularik Inc Pentafluorobenzenossulfonamidas e analogos
AU1208999A (en) 1997-11-10 1999-05-31 Array Biopharma, Inc. Compounds which inhibit tryptase activity
JP2001526255A (ja) 1997-12-23 2001-12-18 ワーナー−ランバート・カンパニー 炎症性疾患およびアテローム性動脈硬化症を治療または予防するチオ尿素およびベンズアミド化合物、組成物並びに方法
DE69908156T2 (de) * 1998-09-23 2003-12-24 Tularik, Inc. Arylsulfonanilid-harnstoffe
RU2268054C2 (ru) * 1999-07-29 2006-01-20 Амджен Инк. Сочетанная терапия с использованием пентафторбензолсульфонамидов

Similar Documents

Publication Publication Date Title
BE2018C020I2 (https=)
BE2015C057I2 (https=)
BE2016C007I2 (https=)
BE2015C018I2 (https=)
BE2014C017I2 (https=)
BE2013C051I2 (https=)
BE2013C020I2 (https=)
BE2013C015I2 (https=)
BE2013C001I2 (https=)
BE2012C036I2 (https=)
BE2008C046I2 (https=)
BE1025464I2 (https=)
BE2010C011I2 (https=)
BRPI0017527B8 (https=)
BE2008C047I2 (https=)
BE2011C004I2 (https=)
JP2002526174A5 (https=)
BRPI0001672A2 (https=)
BRPI0001542A2 (https=)
JP2002526472A5 (https=)
JP2002524888A5 (https=)
JP2002521420A5 (https=)
BRPI0012675B8 (https=)
JP2002516548A5 (https=)
BRPI0017522A2 (https=)